Bioasis Technologies has formed a research collaboration with Aposense Limited. Aposense is an Israeli bio-pharmaceutical company specializing in the development of novel drugs utilizing membrane electrical forces … more
Bioasis reports the publication of research validating the ability of the company’s xB3™ platform to efficiently deliver siRNA across the blood-brain barrier to the central nervous system in therapeutically relevant doses … more